Skip to main content
logo
Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
4.410
+0.230 (5.50%)
At close: Jul 10, 2026, 4:00 PM EDT
4.410
0.00 (0.00%)
After-hours: Jul 10, 2026, 4:00 PM EDT

Bicycle Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-219.03-218.96-169.03-180.66-112.72-66.82
Depreciation & Amortization
5.926.427.176.553.691.41
Stock-Based Compensation
36.7939.4638.0832.4826.7812.08
Other Adjustments
0.23-0.85-7.54.35-4.53-1.2
Change in Receivables
0.13--2.48-1.644.54
Changes in Accounts Payable
-5.69-6.873.182.561.2
Changes in Accrued Expenses
9.954.099.72.412.361.19
Changes in Unearned Revenue
-60.17-69.19-31.9568.95-2.1437.12
Changes in Other Operating Activities
2.65-3.78-14.29-5.17-10.48-4.31
Operating Cash Flow
-229.23-249.68-164.72-60.63-86.11-14.79
Capital Expenditures
-2.46-2.35-1.24-2.93-18.99-2.03
Investing Cash Flow
-2.46-2.35-1.24-2.93-18.99-2.03
Long-Term Debt Issued
-----15
Long-Term Debt Repaid
-0.19-0.17-31.91---
Net Long-Term Debt Issued (Repaid)
-0.19-0.17-31.91--15
Issuance of Common Stock
0.050.04551.66250.036.69305.73
Net Common Stock Issued (Repurchased)
0.050.04551.66250.036.69305.73
Financing Cash Flow
-0.14-0.13519.75250.036.69320.73
Effect of Exchange Rate Changes on Cash and Cash Equivalents
-1.610.8-0.691.35-1.12-1.21
Net Cash Flow
-233.44-251.35353.1187.82-99.53302.69
Free Cash Flow
-231.69-252.03-165.96-63.56-105.1-16.82
FCF Margin
-364.89%-347.21%-470.47%-235.61%-726.67%-143.83%
Free Cash Flow Per Share
-3.34-3.64-2.85-1.79-3.54-0.67
Levered Free Cash Flow
-269.03-290.81-228.44-102.87-125.7-17.25
Unlevered Free Cash Flow
-293.72-318.92-231.63-113.69-128.08-29.46
SEC Filings: 10-K · 10-Q